|
|
|
|
P-072 / P-072-1ML updated item number format
Pregabalin-D6
100 ug/mL in Methanol | Certified Reference Material
|
|
Pregabalin, marketed as the anticonvulsant drug Lyrica, is used in the treatment of epilepsy and generalized anxiety disorder. Along with other anticonvulsants such as gabapentin and levetiracetam, pregabalin is also used to treat neuropathic pain. This new internal standard is suitable for use in the quantitation of patient levels using LCMS applications.
|
|
|
|
|
| Concentration:
|
100 ug/mL
|
| Solvent:
|
Methanol
|
| Unit Size:
|
1 mL/ampoule
|
| CAS Number:
|
Not available
|
| Chemical Formula:
|
C8D6H11NO2
|
| Molecular Weight:
|
165.26
|
| Certificate of Analysis:
|
|
| US List Price:
|
|
|
|
|
| G-007 / G-007-1ML |
|
Gabapentin, 1.0 mg/mL
|
|
$75.00
|
|
|
|
|
|
| G-017 / G-017-1ML |
|
Gabapentin-D10, 1.0 mg/mL
|
|
$1,830.00
|
|
|
|
|
|
| G-018 / G-018-1ML |
|
Gabapentin-13C3, 100 µg/mL
|
|
$206.00
|
|
|
|
|
|
| G-021 / G-021-1ML |
|
Gabapentin, 10 mg/mL
|
|
$222.00
|
|
|
|
|
|
| G-901 / G-901-1ML |
|
Gabapentin-D10, 100 μg/mL
|
|
$191.00
|
|
|
|
|
|
| P-066 / P-066-1ML |
|
Pregabalin, 1.0 mg/mL
|
|
$215.00
|
|
|
|
|
|
| P-096 / P-096-1ML |
|
Pregabalin-D6, 1.0 mg/mL
|
|
$521.00
|
|
|
|
|
|
| P-106 / P-106-1ML |
|
Pregabalin-13C3, 100 µg/mL
|
|
$279.00
|
|
|
|
|
|
| P-120 / P-120-1ML |
|
Pregabalin, 10 mg/mL
|
|
$614.00
|
|
|
|
|
|
| R-023 / R-023-1ML |
|
Rufinamide, 1.0 mg/mL
|
|
$161.00
|
|
|
|
|
|
| V-022 / V-022-1ML |
|
Vigabatrin, 1.0 mg/mL
|
|
$170.00
|
|
|
|
|
|
▶ Evaluation of LCMS/MS scrambling ratios for deuterium-labeled Vitamin D metabolites, steroids and other compounds of clinical significance | Yunming Ying, Huahua Jian, Isil Dilek, Uma Sreenivasan, Cerilliant, 2011
|
|
▶ Mitigation of Deuterium Scrambling in Stable-Labeled Internal Standards during LC-MS/MS Analysis | Joshua Cooper, Billy Molloy, Huahua Jian, Lisa Calton, Derrell Johnson, Isil Dilek, Uma Sreenivasan, Don Cooper, Cerilliant, 2011
|
|
▶ Ultrafast Analysis of Six Antiepileptic Drugs in Serum by the Agilent RapidFire High-Throughput Mass Spectrometry System | Mohamed Youssef and Vaughn P. Miller, Agilent Technologies, Inc., 2013
|
|
▶ Ultrafast Analysis of Six Antiepileptic Drugs in Serum by the Agilent RapidFire High-Throughput Mass Spectrometry System | William C. Hudson, Agilent Technologies, Inc., 2013
|
|
|
|
|